福安药业：国家层面已优化集采措施

Group 1 - The core viewpoint of the article highlights that Fuan Pharmaceutical is actively responding to investor concerns regarding measures against internal competition in the pharmaceutical industry [2] - The company emphasizes that at the national level, procurement measures have been optimized to adhere to principles such as "stabilizing clinical practices, ensuring quality, preventing collusion, and combating internal competition" [2] - Fuan Pharmaceutical indicates that these efforts have led to a gradual normalization of industry order, reduced the burden of medication costs for the public, and improved the overall quality and accessibility of medications [2]